Long-circulating Gd2O3:Yb3+, Er3+ up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging

Biomaterials

Volumn 34, Issue 6, 2013, Pages 1712-1721

  Liu, Zhen ^a,b   Pu, Fang ^a   Huang, Sa ^c   Yuan, Qinghai ^c   Ren, Jinsong ^a   Qu, Xiaogang ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Contrast agent; Long circulating; Multi modality imaging; Nanoprobe; Toxicology

Indexed keywords

BIODISTRIBUTIONS; BLOOD CIRCULATION; CONTRAST AGENT; HIGH QUALITY; HYDROTHERMAL SYSTEM; IN-SITU THERMAL DECOMPOSITION; IN-VIVO; INTRAVENOUS INJECTIONS; LONG-CIRCULATING; MOUSE MODELS; MULTI-MODALITY; SMALL-ANIMAL; SURFACE-MODIFIED; TOXICOLOGY; UP-CONVERSION; UP-CONVERSION LUMINESCENCE; X-RAY COMPUTED TOMOGRAPHY;

CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; CYTOTOXICITY; DECOMPOSITION; DIAGNOSIS; ELECTRIC PROPERTIES; ERBIUM; GADOLINIUM; MAGNETIC RESONANCE; NANOPROBES; NANORODS; OPTICAL PROPERTIES; POLYETHYLENE GLYCOLS; YTTERBIUM;

POLYETHYLENE OXIDES;

CONTRAST MEDIUM; ERBIUM; NANOMATERIAL; YTTERBIUM;

ANIMAL EXPERIMENT; ARTICLE; CIRCULATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; HEMATOLOGY; HEMOLYSIS; HISTOLOGY; IMAGING SYSTEM; IN VIVO STUDY; INFLAMMATION; LUMINESCENCE; MOLECULAR STABILITY; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; UP CONVERSION LUMINESCENCE;

ANIMALS; CELL LINE, TUMOR; CONTRAST MEDIA; ERBIUM; GADOLINIUM; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; RATS; RATS, WISTAR; YTTERBIUM;

ANIMALIA;

EID: 84870787606     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.11.009     Document Type: Article

References (57)

1. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
2. Welsher K., Liu Z., Sherlock S., Robinson J., Chen Z., Daranciang D., et al. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat Nanotechnol 2009, 4:773-780.
3. Seo W.S., Lee J.H., Sun X.M., Suzuki Y., Mann D., Liu Z., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
4. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:H18-H40.
5. Xue X.J., Wang F., Liu X.G. Emerging functional nanomaterials for therapeutics. J Mater Chem 2011, 21:13107-13127.
6. Yang H., Xia Y.N. Bionanotechnology: enabling biomedical research with nanomaterials. Adv Mater 2007, 19:3085-3087.
7. Jun Y.W., Choi J.S., Cheon J. Heterostructured magnetic nanoparticles: their versatility and high performance capabilities. Chem Commun 2007, 43:1203-1214.
8. Taylor-Pashow K., Rocca J.D., Huxford R.C., Lin W.B. Hybrid nanomaterials for biomedical application. Chem Commun 2010, 46:5832-5849.
9. Cai W.B., Chen X.Y. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
10. Rhyner M.N., Smith A.M., Gao X.H., Mao H., Yang L., Nie S.M. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine-UK 2006, 1:209-217.
11. Rabin O., Perez J.M., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
12. Skotland T. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use. Contrast Media Mol Imaging 2012, 7:1-6.
13. 4:Yb/Er upconversion nanoparticles for in vivo imaging and drug delivery. Adv Mater 2012, 24:1226-1231.
14. 3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv Mater 2011, 23:4886-4891.
15. Oh M.H., Lee N., Kim H., Park S.P., Piao Y.Z., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 2011, 133:5508-5515.
16. Kinsella J.M., Jimenez R.E., Karmali P.P., Rush A.M., Kotamraju V.R., Gianneschi N.C., et al. X-Ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed 2011, 50:12308-12311.
17. Sun C., Du K., Fang C., Bhattarai N., Veiseh O., Kievit F., et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano 2010, 4:2402-2410.
18. Mader H.S., Kele P., Saleh S.M., Wolfbeis O.S. Upconverting luminescent nanoparticles for use in bioconjugation and bioimaging. Curr Opin Chem Biol 2010, 14:582-596.
19. 64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc 2010, 132:15351-15358.
20. Ma M., Che H.R., Chen Y., Wang J., Chen F., Cui X.Z., et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging. Biomaterials 2012, 33:989-998.
21. x core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. J Am Chem Soc 2012, 134:10309-10312.
22. Alric C., Taleb J., Duc G.L., Mandon C., Billotey C., Meur-Herland A.K., et al. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 2008, 130:5908-5915.
23. Hu J., Xie M., Wen C.Y., Zhang Z.L., Xie H.Y., Liu A.A., et al. A multicomponent recognition and separation system established via fluorescent, magnetic, dual encoded multifunctional bioprobes. Biomaterials 2011, 32:1177-1184.
24. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
25. 18F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assisted ligand assembly. ACS Nano 2011, 5:3146-3157.
26. Liu Q., Chen M., Sun Y., Chen G.Y., Yang T.S., Gao Y., et al. Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence/fluorescence/positron emission tomography imaging. Biomaterials 2011, 32:8243-8253.
27. Taylor K.M.L., Jin A., Lin W.B. Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. Angew Chem Int Ed 2008, 47:7722-7725.
28. Zhou J., Liu Z., Li F.Y. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41:1323-1349.
29. 3+-chelated mesoporous silica shells. ACS Nano 2011, 5:3905-3916.
30. 3 nanoparticles and their applications for optical and magnetic resonance imaging. J Mater Chem 2012, 22:966-974.
31. 4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications. ACS Nano 2012, 6:2969-2977.
32. 4 nanocrystals as potential optical/magnetic multimodal bioprobes. J Am Chem Soc 2012, 134:1323-1330.
33. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
34. Liu Z., Liu X., Yuan Q.H., Dong K., Jiang L.Y., Li Z.Q., et al. Hybrid mesoporous gadolinium oxide nanorods: a platform for multimodal imaging and enhanced insoluble anticancer drug delivery with low systemic toxicity. J Mater Chem 2012, 22:14982-14990.
35. 3 nanorods and their potential for oral drug delivery and MR imaging. Biomaterials 2010, 31:6843-6848.
36. 4:Yb, Tm nanocrystals. Biomaterials 2011, 32:9059-9067.
37. 3: synthesis and applications of magnetic resonance contrast agents and template particles for hollow spheres and hybrid composites. Adv Funct Mater 2008, 18:766-776.
38. Xing H.Y., Bu W.B., Zhang S.J., Zheng X.P., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
39. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
40. 3 up-conversion nanoparticle as an in vivo X-Ray CT imaging contrast agent. Biomaterials 2012, 33:6748-6757.
41. Liu Y.L., Ai K.L., Liu J.H., Yuan Q.H., He Y.Y., Lu L.H. A high-performance ytterbium-based nanoparticulate contrast agent for in vivo X-Ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
42. 4:Yb, Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging. Biomaterials 2012, 33:4618-4627.
43. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
44. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine-UK 2011, 6:715-728.
45. Peng C., Zheng L.F., Chen Q., Shen M.W., Guo R., Wang H., et al. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 2012, 33:1107-1119.
46. Yue Z.G., Wei W., You Z.X., Yang Q.Z., Yue H., Su Z.G., et al. Iron oxide nanotubes for magnetically guided delivery and pH-activated release of insoluble anticancer drugs. Adv Funct Mater 2011, 21:3446-3453.
47. Lin Y.S., Haynes C.L. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. J Am Chem Soc 2010, 132:4834-4842.
48. Slowing I.I., Wu C.W., Vivero-Escoto J.L., Lin V.S.Y. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
49. Dev K.C., Zhang Y. Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine-UK 2008, 3:73-82.
50. Ang L.Y., Lim M.E., Ong L.C., Zhang Y. Applications of upconversion nanoparticles in imaging, detection and therapy. Nanomedicine-UK 2011, 6:1273-1288.
51. Wang F., Deng R.R., Wang J., Wang Q.X., Han Y., Zhu H.M., et al. Tuning upconversion through energy migration in core-shell nanoparticles. Nat Mater 2011, 10:968-973.
52. Shilo M., Reuveni T., Motiei M., Popovtzer R. Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine-UK 2012, 7:257-269.
53. Pan D., Schirra C.O., Senpan A., Schmieder A.H., Stacy A.J., Roessl E., et al. An early investigation of ytterbium nanocolloids for selective and quantitative " multicolor" spectral CT imaging. ACS Nano 2012, 6:3364-3370.
54. Yu S.B., Watson A.D. Metal-based X-ray contrast media. Chem Rev 1999, 99:2353-2377.
55. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 2008, 8:4593-4596.
56. Wang H., Zheng L.F., Peng C., Guo R., Shen M.W., Shi X.Y., et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials 2011, 32:2979-2988.
57. Cheng L., Yang K., Shao M.W., Lu X.H., Liu Z. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine-UK 2011, 6:1327-1340.